An update of pitfalls in prostate mpMRI: a practical approach through the lens of PI-RADS v. 2 guidelines
- 3.9k Downloads
The aim of the current report is to provide an update in the imaging interpretation of prostate cancer on multiparametric magnetic resonance imaging (mpMRI), with a special focus on how to discriminate pathological tissue from the most common pitfalls that may be encountered during daily clinical practice using the Prostate Imaging Reporting and Data System (PI-RADS) version 2 guidelines.
All the cases that are shown in this pictorial review comply with the European Society of Urogenital Radiology (ESUR) guidelines for technical mpMRI requirements.
Despite the standardised manner to report mpMRI (PI-RADS v. 2), some para-physiologic appearances of the prostate can mimic cancer. As such, it is crucial to be aware of these pitfalls, in order to avoid the under/overestimation of prostate cancer.
A detailed knowledge of normal and abnormal findings in mpMRI of the prostate is pivotal for an accurate management of the wide spectrum of clinical scenarios that radiologists may encounter during their daily practice.
• Some para-physiologic appearances of the prostate may mimic cancer.
• Knowledge of normal and abnormal findings in prostate mpMRI is pivotal.
• Any radiologist involved in prostate mpMRI reporting should be aware of pitfalls.
KeywordsProstate Prostatic cancer Magnetic resonance imaging Diagnosis Pitfalls
Wide spectrum of pitfalls and different classifications
Pitfall vs Pitfall
1. Hypertrophic anterior fibromuscular stroma
1. Moustache sign (small bilateral BPH nodules against the PZ)
2. Moustache-like sign (larger adenoma against the PZ)
3. Teardrop sign (median posterior compressed central zone)
4. Teardrop-like sign (Protruding BPH above the verumontanum)
5. Ectopic BPH nodule
1. Periprostatic venous plexus
2. Neurovascular bundle
Mispositioned endorectal coil
I. PCa in moustache sign
II. PCa in median posterior change (compressed central zone and BPH proliferation) in reversed teardrop
III. Ectopic BPH nodule vs abscess
However, inter-reader variability represents a real limitation for prostate mpMRI, and expertise in reporting is crucial to improve cancer detection and staging accuracy. Therefore, it is important to validate the current protocols . In 2012, the European Society of Urogenital Radiology (ESUR) set up an expert panel to develop a standardised system for prostate mpMRI interpretation and reporting, under the name of Prostate Imaging Reporting and Data System (PI-RADS) . In 2015 a revision of this classification led to the publication of PI-RADS v. 2 , with the aim to promote a global standardisation of these guidelines, and to reduce the variability in the acquisition, interpretation and reporting of prostate mpMRI. A detailed explanation of PI-RADS v. 2 is beyond the aim of this report, but it is worth summarising the main points of these guidelines: (1) DWI is the dominant sequence in the peripheral zone (PZ); (2) T2-weighted imaging (T2-WI) is the dominant sequence in the transitional zone (TZ); (3) the role of DCE is secondary to DWI in the PZ; and (4) there is an overall 5-point (from 1 to 5) PI-RADS assessment (1: low probability – 5: very high probability of clinically significant cancer).
Nonetheless, the interpretation of mpMRI of the prostate can be challenging and new radiological skills are needed, especially when potential pitfalls (i.e., normal anatomic structures, benign conditions of the prostate or artefacts due to technical issues) might be erroneously interpreted as pathological conditions. Moreover, the PI-RADS v. 2 guidelines may be subject to some interpretation variability according to the radiologists’ individual experience, lowering the ability to distinguish pitfalls from true malignancy . Awareness of these pitfalls is therefore fundamental.
Currently, there are only three reports (two from the United States and one from Europe) [9, 10, 11] addressing the mpMRI pitfalls in PCa. They have all suggested some strategies to assist the radiologists in avoiding misdiagnosis (and consequently mistreatment), but a systematic approach on how to tackle these aspects applying PI-RADS v. 2 has yet to be reported.
Therefore, the purpose of this article is to provide a practical approach for imaging interpretation in PCa, with a special focus on how to apply PI-RADS v. 2 to discriminate pathological conditions from the most common pitfalls that could be encountered during daily clinical practice. Of note, this report is based on a pragmatic consensus among a panel of different international radiologists highly experienced in mpMRI of the prostate (VP, FG, YXK, FC, GV).
PITFALLS and PI-RADS v.2
For the sake of completeness, the cases shown in this pictorial report represent a cohort of men aged 47–79 years, with prior suspicion of PCa based on abnormal digital rectal examination, rise of prostate specific antigen (PSA) and/or family history of PCa. The exams have been acquired on a 3.0 T system (Discovery MR750, GE Healthcare, Waukesha, WI), by using a 32 multi-channel (or 8 multi-channel + endorectal coil) surface phased-array body coil.
Awareness of diagnostic pitfalls is important to avoid both false-positive and false-negative interpretations. A systematic approach to mpMRI of the prostate using PI-RADS v. 2 helps in the identification of PCa, but there still remains a wide spectrum of pitfalls. These can be broadly split into two main groups: (1) pitfalls related to clinical indications and (2) technical and physiological artefacts (Table 1).
Pitfalls related to clinical indications
These pitfalls are related both to the anatomy of the prostate and to certain benign conditions of the gland, which can mimic the presence of cancer. The typical appearance of PCa in the PZ is a focal hypointense area on T2-WI; however, other benign conditions, such as prostatitis, fibro-muscular bands and post-biopsy haemorrhage can mimic this signal change, leading to potential misdiagnoses.
Hypertrophic anterior fibromuscular stroma
Periprostatic neurovascular bundle
The periprostatic vascular (sometimes venous) plexus courses around the lateral margins of the prostate (i.e., very close to the capsule) and can show a congested appearance, particularly in men with prostatitis.
Sometimes it is difficult to separate the plexus from the PZ on mpMRI, due to focal low T2 signal intensity. This makes the use of PI-RADS v.2 mandatory.
The neurovascular bundle courses along the posterolateral margin of the prostate, near the prostate capsule, at approximately a 5- and 7-o’clock position.
Similar to the periprostatic vascular plexus, the neurovascular bundle, when visible, can mimic the presence of a lesion in the PZ (mimicking T3a disease).
In case of a tumour located adjacent to the periprostatic neurovascular bundle, the distinction might not be easy due to the absence of the adipose plane between them. At this regard, DCE sequences can be of help due to the different behaviour after contrast injection (early vs late/mild enhancement). Additionally, the coronal plane can help to localise the neurovascular bundle and the continuity of the capsule in another plan.
Moreover, mpMRI is increasingly being used in the decision-making pathway of PCa, to support the choice of a nerve-sparing approach when possible. In this regard, the use of diffusion-tensor imaging from mpMRI holds promise for the future .
Bilateral benign prostatic hyperplasia proliferation (moustache sign)
On the contrary, foci of PCa generally show a more heterogeneous appearance, with ill-defined margins.
Histologically, the low signal intensity reflects respectively the compressed central gland, with hypertrophic tissue, and the different glandular pattern of BPH, with increased cellularity. In both cases, this sign typically appears as a symmetrical oval shape, with sharp margins and a homogeneous, low signal intensity.
These regions can also be characterised by restricted diffusion and homogeneous/positive enhancement. Protrusion of BPH nodules shows homogeneous enhancement, whereas the compressed central zone usually does not.
According to PI-RADS v. 2, a potential score for this pitfall could be 3–4/5 for T2-WI, 4/5 for DWI (in case of marked restriction of diffusion) and early enhancement (+) on DCE; such scenario would orient towards the presence of clinically significant PCa and might suggest biopsy. However, if we apply PI-RADS v. 2 after carefully considering other distinguishing features (e.g., the use of the coronal T2 weighted sequence, the presence of sharp margins and a symmetrical pattern), we can correctly score this condition as 2/5 both on T2-WI and DWI, excluding the presence of cancer (Figs. 4 and 5). It follows that an appropriate use of PI-RADS v. 2 guidelines is based on the knowledge and awareness of the anatomy related to BPH nodules in the central zone.
We also want to stress that the key feature to differentiate a pitfall from PCa is the symmetry of the finding. An asymmetrical area characterised by lower signal intensity on T2-WI with respect to the background (3) together with a marked, focal enhancement (+) and higher grade of restriction on DWI (4) suggests a suspicious lesion in this context.
Median posterior BPH proliferation (teardrop sign)
Here, the pitfall is related to a posterior bulging of the central zone above the verumontanum, between the TZ and the PZ (teardrop), and could show mild, restricted diffusion and focal contrast uptake. The low signal intensity of this finding on T2-WI is due to the hypertrophic tissue that follows the ejaculatory ducts before entering the prostatic urethra.
An area that is not in continuity with the central portion of the prostate, characterised by marked low signal intensity on T2-WI (scored as 4/5) together with an early uptake of contrast (+) and a high grade of restriction on DWI (scored as 4/5) can be correctly classified as a highly-suspicious lesion.
Ectopic BPH nodule
However, as there are no established guidelines that suggest scoring a TZ lesion that protrudes into the PZ using the dominant sequence from the TZ (rather than PZ), we deem that in this scenario the experience of the radiologist and the knowledge of prostate anatomy and specific morphological features of BPH (e.g., regular capsule and margins) are more important than ever.
This condition is usually caused by E. coli or Staphylococcus infections, and can ultimately result in the formation of an abscess.
On mpMRI, focal prostatitis can show an area of decreased signal on T2-WI (from nodular to band-like) in the PZ (adjacent to the capsule and infiltrating the periprostatic fat; hence, mimicking extracapsular extension – T3 stage) and increased perfusion on DCE (+), yielding a “false positive” finding. Additionally, the ADC map can be characterised by an area of low signal intensity.
Therefore, final histopathology is regarded as the only means to carry out an accurate diagnosis and to exclude the presence of tumour.
In addition, the radiologist should keep in mind that also granulomatous prostatitis can occur in the prostate. This usually presents as a firm nodule on digital rectal examination and elevated PSA, thus mimicking PCa. Although there can be different causes (instillation of intravesical bacille of Calmette-Guérin for bladder cancer, tuberculosis, surgical procedures), most cases are usually idiopathic .
Abscess vs cancer
In the PZ, it is possible to find a round-shaped region characterised by inhomogeneous, low-signal intensity on T2-WI, with a pseudocapsule (scored as 2/5), together with ring enhancement on DCE (+) and restriction on DWI (scored as 4/5).
Haemorrhage and other pitfalls
The presence of haemorrhage after prostate biopsy is relatively frequent. In fact, citrate is normally produced by the prostate for preserving the semen, but it is also an endogenous anticoagulant that can lead to protracted bleeding and non-coagulation of blood after biopsy. The latter may cause decreased T2 signal intensity that could mimic or obscure a suspicious area for PCa. Using a strict approach of PI-RADS v.2 guidelines, this should be grading as 4/5 on T2 and 4/5 on DWI, with a low ADC. However, the pre-contrast T1-WI can help to differentiate this area from a suspicious focus of PCa, as it shows a mild hyperintense signal due to the products from the haemoglobin degradation. This will be also supported by the corresponding hypointense signal in the post-contrast subtraction imaging.
Focal atrophy - particularly the post-atrophic hyperplastic subtype - may mimic PCa on mpMRI due to the glandular crowding and complex architecture. Causes of atrophy include inflammation, irradiation, antiandrogen therapy, and chronic ischaemia from local arteriosclerosis. Focal atrophy occurs more frequently in the PZ and appears as a focal or geographical area of low T2 signal intensity on mpMRI, with both moderate diffusion restriction and enhancement. The degree of restriction and tissue enhancement are usually less marked than PCa.
Necrosis can be seen after the resolution of the abscess and florid inflammatory changes from an infectious prostatitis, or after focal therapy. Necrosis shows low T2 signal intensity and diffusion restriction, due to the coagulative state characterised by reduced water movement, as well as by the adjacent inflammatory infiltrate and atrophy. There is also no enhancement. Together, these features suggest the presence of necrosis and fibrosis on mpMRI.
Calcification is due to concreted prostatic secretions, calcified corpora amylacea and phleboliths in the periprostatic venous plexus. Calcifications show low signal intensity on T2-WI and ADC images, together with no enhancement and a persistent, marked low signal intensity on DWI at all b values.
All the aforementioned pitfalls (focal atrophy, necrosis and calcifications) have specific features that help to distinguish them from PCa when applying PI-RADS v. 2 (e.g., no enhancement or less restriction on DWI).
Pitfalls related to technical and physiological artefacts
The use of an endorectal coil in addition to the surface coil improves the signal-to-noise ratio and the spatial resolution both at 1.5 and 3 T. On the contrary, patient or bowel movements during image acquisition may cause repetitive circular artefacts along the boundaries of the endorectal coil. These artefacts can be minimised by rectal emptying and by the administration of a spasmolytic drug prior to the examination.
According to PI-RADS v. 2, an area of homogeneous low-signal intensity on T2-WI in the PZ, showing restricted diffusion on DWI and focal enhancement (+) can be scored as 4/5, suggesting the presence of clinically significant PCa. However, the use of a single surface coil could erroneously suggest extracapsular extension (T3 stage) because of the lower resolution. In this case, the application of PI-RADS v. 2 together with the use of the endorectal coil could help to rule out capsular involvement (T2 stage), thanks to the increased resolution.
To sum up, there are different artefacts that can mimic the presence of PCa and which the radiologist should be aware of. These include the presence of gas in the rectum, and the interpretation of ADC maps with low-value pixels, as these latter can show the same dark signal as fat, creating problems for lesions along the capsule. As far as the use of spasmolytic agents is concerned, the radiologist should bear in mind that many patients undergoing mpMRI will have a large prostate due to BPH (with related urinary problems). Therefore, these medications should be administered carefully and preferably before positioning the patient on the mpMRI table. Glucagon should be chosen in patients with urinary retention.
Since its introduction, mpMRI of the prostate has been changing the management of suspicious PCa, especially in men with non-specific high PSA, where the detection of clinically significant PCa has been shown to be more accurate than standard TRUS biopsy . Despite the standardised attempts to report mpMRI (PI-RADS v 2) , some para-physiologic appearances of the prostate gland can mimic cancer. As there are no established guidelines that suggest scoring a TZ lesion that protrudes into the PZ using the dominant sequence from the TZ (rather than PZ), we deem that in this scenario the experience of the radiologist and the knowledge of prostate anatomy and specific morphological features of BPH (e.g., regular capsule and margins) are more important than ever. Moreover, we believe that the radiologist should be aware of clinical data such as the exposure to antiandrogen therapy for BPH, as this could affect the conspicuity of tumours in the TZ as well as on DWI. The radiologist should also keep in mind that other sequences (e.g., DWI) can be of great help while reporting prostate mpMRI, if there are some doubts on T2-WI, as suggested by the PI-RADS v. 2 guidelines [15, 16, 17, 18, 19, 20, 21]. Although these guidelines use DWI to upgrade some PI-RADS 3 lesions in the TZ to PI-RADS 4, DWI alone is nonetheless a sensitive sign for detection of tumours even in the TZ [22, 23]. Rosenkrantz and colleagues  reported that the incorporation of DWI and ADC maps (b value:1000 s/mm2) significantly improves the sensitivity for TZ tumours compared with T2-WI alone. The main reason is the diffuse background heterogeneity and the presence of multiple nodules in the TZ, which make tumours harder to identify on T2-WI. As known, DWI investigates the movement of water molecules within tissues and reflects changes in cellularity; thus, it provides complementary information that may help depict lesions not initially visible on T2-WI, leading to improved sensitivity.
In conclusion, we recommend that any radiologist involved in prostate mpMRI be fully aware of the pitfalls mentioned in this pictorial report, in order to avoid underestimation and overestimation of PCa detection. We also deem that this manuscript gives a repertoire of potential solutions for the improvement of the future PI-RADS guidelines.
- 20.Giganti F et al (2017) MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial. Eur Radiol. https://doi.org/10.1007/s00330-017-4858-0
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.